Deal date

KANDO id: 742441

Financial Transaction:

Series B


NBE-Therapeutics AG


Currency
Swiss Franc
Value in original currency
20,000,000
Value in USD
20,500,000

Lead investor

Country Notes

PPF Group


Round participants

Country Notes

Boehringer Ingelheim Venture Fund GmbH

(BIVF)